DHCR24: A Novel HCC Biomarker at a GlanceKhadija Rebbani and Kyoko Tsukiyama-Kohara*
Department of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan
- *Corresponding Author:
- Kyoko Tsukiyama-Kohara
Transboundary Animal Diseases Center & Department of Animal Hygiene
Joint Faculty of Veterinary Medicine
Kagoshima University, 1-21-24 Korimoto
Kagoshima 890-0065, Japan
E-mail: [email protected]
Received Date: December 12, 2015; Accepted Date: December 28, 2015; Published Date: December 30, 2015
Citation: Rebbani K, Tsukiyama-Kohara K (2015) DHCR24: A Novel HCC Biomarker at a Glance. Clin Microbiol 4:228. doi:10.4172/2327-5073.1000228
Copyright: © 2015 Rebbani K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The sustained increase of hepatocellular carcinoma (HCC) new cases and the failure of determining a “universal” biomarker for early detection are sounding the alarm about finding urgently new alternatives and develop new biomarkers in order to face this public health issue. Hereby, a highlight of new findings about the involvement of 3β-hydroxysterol Δ24-reductase (DHCR24) as a potential biomarker of hepatitis C disease progression to hepatocellular carcinoma and a valuable target for hepatitis C virus (HCV) related HCC therapy.